Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RUltragenyx Pharmaceutical Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Ultragenyx Pharmaceutical Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 15, 2026Huizenga Theodore AlanSVP, Chief Accounting Officer1,283Common Stock—Sell
Sep 3, 2026Huizenga Theodore AlanSVP, Chief Accounting Officer161Common Stock—Sell
Aug 3, 2026Horn HowardChief Financial Officer4,696Common Stock—Sell
Aug 3, 2026Parschauer Karah HerdmanEVP and Chief Legal Officer1,900Common Stock—Sell
Jul 1, 2026Horn HowardChief Financial Officer4,698Common Stock—Sell
Jun 15, 2026Parschauer Karah HerdmanEVP and Chief Legal Officer1,899Common Stock—Sell
Jun 15, 2026Sanders Corazon (Corsee) D.Director2,000Common Stock—Sell
Jun 1, 2026Horn HowardChief Financial Officer4,653Common Stock—Sell
May 18, 2026SULIMAN SHEHNAAZDirector5,740Common Stock—Sell
May 14, 2026Dunsire DeborahDirector14,058Stock Option (Right to Buy)—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions